Smarter Investment and value realisation
Australia spends $7.6 billion a year on health and medical research and innovation. We make the case for investing in strategically.
Our position: health and medical research and innovation needs strategic investment across the full pipeline, from discovery to implementation. That’s how we maximise its health, economic and social impact, and strengthen Australia’s global competitiveness. We produce evidence and bring the sector together to make that case.
CASE STUDY
What we did, and what happened next
A funding gap we identified saw the government commit to lifting MRFF disbursements to $1 billion a year from 2030-31.
What we Focused On
When the Medical Research Future Fund was set up, the Government of the day promised that once the fund reached $20 billion, it would release $1 billion a year for research. That never happened. In 2023, we identified that the funding available for MRFF grants exceeded the $650 million a year being released, so money meant for research was going unspent.
What we did
We convened the sector around the evidence and advocated for the full funds to be released. We made the case in our pre-budget submissions (2025 and 2026-27) and met with decision-makers to press for disbursement transparency and long-term funding certainty.
What happened in the system
In the May 2026 Budget, the Government committed to lifting MRFF disbursements to $1 billion a year from 2030-31, up from $650 million. It’s a commitment, not yet a disbursement.
The Case for Investing
Why research funding pays
$4
returned to the Australian economy for every $1 invested in health and medical research.
Source: HMR Facts, 2026

1.69%→3%
Australia invests 1.69% of GDP in R&D. We’re calling for a measurable path to 3%.
Sources: ABS, 2023-24; Research Australia, Submission to the Strategic Examination of R&D, April 2025.
78%
of Australians name increased health and medical research funding a key government spending priority.
Source: 2025 Research Australia Public Opinion Poll (Roy Morgan)
The Proof
Evidence on this platform
Every item below is citable.
Report
Arthritis
2026
The MRFF & government funding
Disbursement analysis across five years of missions.
Report
Clinical trials
2025
Pre-budget submission 2026–27
Submitted by Research Australia on behalf of our members, January 2026.
Communique
Digital health
2025
Pre-budget submission 2025–26
Submitted by Research Australia on behalf of our members, January 2025.
Help shape the investment agenda
Members set the priorities we take to government. Join or partner with us on a strategic project.